1006 / 1119
Interpretation of RetroEMBRACE results (IGABT
compared to large population based cohorts 2D BT)
Pelvic failure
(crude)
Concomitant
chemo
IB
IIB
IIIB
retroEMBRACE
(n=731)
77%
4%
11%
25%
Perez 1998
0%
12%
21%
41%
Barillot 1997
0%
13%
24%
49%
Improvement
Δ8-9%
Δ10-13%
Δ16-24%
Overall
Survival
Radio-chemo
retroEMBRACE
Consecutive
3D/4D IGABT
UK Survey
Vale 2010
2D BT
US SEER
2000-2009
2D BT
US NCDBA
2004-2011
2D BT
No of pts
394
471
3246
2571
5y OS
Improvement
67%
Reference
55%
Δ12%
55%
Δ12%
54%
Δ13%
13%
23%
Δ10
%
total